Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
CN Stock MarketDetailed Quotes
Shanghai Labway Clinical Laboratory (301060)
- 10.66
- +0.19+1.81%
Market Closed May 7 15:00 CST
4.27BMarket Cap296.11P/E (TTM)
10.84High10.38Low140.47KlotVolume10.43Open10.47Prev Close149.75MTurnover3.90%Turnover RatioLossP/E (Static)400.52MShares14.5552wk High2.69P/B3.84BFloat Cap8.7452wk Low12.56Limit Up360.17MShs Float60.40Historical High8.38Limit Down4.39%Range %7.14Historical Low0.20Dividend TTM10.66Avg Price64.85KlotAsk1.88%Div Yield TTM100Lot Size73.18KlotBid
Shanghai Labway Clinical Laboratory (301060) Cash Flow
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -13.48%347.43M | -21.05%1.64B | -13.93%1.2B | -13.44%781.73M | -4.49%401.58M | -28.27%2.07B | -34.67%1.4B | -34.54%903.1M | -35.51%420.45M | 2.78%2.89B |
| Refunds of taxes and levies | ---- | --0 | ---- | ---- | ---- | --5.87M | ---- | ---- | ---- | ---- |
| Cash received relating to other operating activities | 24.03%6.24M | -23.37%32.17M | -2.98%20.56M | 14.47%12.25M | -10.09%5.03M | 4.41%41.98M | -36.95%21.19M | -60.11%10.7M | -72.14%5.6M | -9.17%40.2M |
| Cash inflows from operating activities | -13.02%353.67M | -21.31%1.67B | -13.77%1.22B | -13.11%793.98M | -4.56%406.61M | -27.62%2.12B | -34.71%1.42B | -35.03%913.8M | -36.60%426.04M | 2.60%2.93B |
| Goods services cash paid | -45.25%158.4M | -33.36%966.03M | -34.25%719.71M | -28.79%527.99M | -15.84%289.3M | -11.61%1.45B | -15.77%1.09B | -3.52%741.42M | -3.29%343.75M | -8.81%1.64B |
| Staff behalf paid | -7.61%64.79M | -1.98%268.48M | -0.99%196.68M | -3.26%135.94M | 1.57%70.12M | -40.69%273.9M | -45.89%198.64M | -53.25%140.53M | -58.66%69.04M | -18.10%461.84M |
| All taxes paid | -26.73%7.28M | -7.03%50.48M | 2.11%38.58M | -9.97%28.1M | -44.58%9.94M | -55.31%54.3M | -61.64%37.79M | -65.22%31.21M | -49.60%17.93M | -37.42%121.5M |
| Cash paid relating to other operating activities | -40.81%21.07M | -9.07%113.53M | -16.56%97.32M | 32.68%64.71M | 4.52%35.6M | -20.69%124.85M | -23.76%116.64M | -55.25%48.77M | -34.78%34.06M | -26.04%157.42M |
| Cash outflows from operating activities | -37.88%251.54M | -26.49%1.4B | -27.32%1.05B | -21.33%756.75M | -12.87%404.96M | -20.08%1.9B | -24.52%1.45B | -24.13%961.94M | -23.84%464.78M | -14.03%2.38B |
| Net cash flows from operating activities | 6,059.57%102.13M | 24.29%268.85M | 707.47%171.76M | 177.35%37.23M | 104.28%1.66M | -60.45%216.31M | -111.05%-28.27M | -134.74%-48.14M | -162.75%-38.74M | 549.88%546.99M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 332.81%1.1B | 729.45%1.91B | 602.90%1.19B | 434.36%748.1M | 409.60%254.8M | -7.02%230M | 259.18%170M | 1,809.96%140M | 533.30%50M | -64.72%247.36M |
| Cash received from returns on investments | 361.36%1.75M | 546.07%4.07M | 394.97%2.85M | 263.33%1.6M | 126.40%379.61K | 12.65%630.1K | 219.61%576.16K | 697.07%439.32K | 69.56%167.67K | -94.12%559.34K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -20.79%574.81K | 40.02%7.84M | 7.69%3.31M | -32.04%2.04M | 2,491.75%725.69K | 40.29%5.6M | 1,313.48%3.08M | 1,482.87%3M | 111.29%28K | -14.65%3.99M |
| Net cash received from disposal of subsidiaries and other business units | -78.74%27.96K | -7.43%3.52M | -7.51%3.33M | 44.93%3.33M | --131.5K | --3.8M | --3.6M | --2.3M | ---- | ---- |
| Cash received relating to other investing activities | ---- | --306.45K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | 331.64%1.11B | 701.33%1.92B | 579.49%1.2B | 418.11%755.06M | 410.08%256.04M | -4.71%240.03M | 271.38%177.25M | 1,824.03%145.73M | 526.88%50.2M | -64.78%251.91M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -67.93%3.81M | -23.66%58.49M | -30.23%36.11M | -36.67%22.7M | -32.75%11.87M | -80.79%76.62M | -85.31%51.76M | 11.62%35.85M | 29.44%17.65M | 73.37%398.89M |
| Cash paid to acquire investments | 236.71%1.04B | 756.71%1.99B | 586.74%1.19B | 419.51%748.1M | 519.40%309.7M | -3.50%232M | 24.29%174M | --144M | --50M | -21.23%240.42M |
| Net cash paid to acquire subsidiaries and other business units | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --11.1M |
| Cash paid relating to other investing activities | ---- | --300K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | 225.47%1.05B | 563.08%2.05B | 445.29%1.23B | 328.58%770.8M | 375.32%321.57M | -52.55%308.62M | -55.15%225.76M | 316.12%179.85M | 173.46%67.65M | 21.51%650.41M |
| Net cash flows from investing activities | 189.34%58.55M | -79.18%-122.88M | 45.13%-26.62M | 53.86%-15.74M | -275.39%-65.54M | 82.79%-68.58M | 89.35%-48.5M | 4.29%-34.12M | -4.33%-17.46M | -321.32%-398.5M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | --0 | ---- | ---- | ---- | -61.41%3.56M | -53.44%3.48M | -48.94%3M | 200.00%3M | -18.25%9.23M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | --0 | ---- | ---- | ---- | -61.41%3.56M | -53.44%3.48M | -48.94%3M | 200.00%3M | -18.25%9.23M |
| Cash from borrowing | ---- | -59.33%50M | -59.33%50M | -55.72%50M | ---- | -66.65%122.93M | -65.76%122.93M | -28.02%112.93M | -87.46%2.5M | 86.17%368.64M |
| Cash received relating to other financing activities | ---- | --0 | --100K | ---- | ---- | ---- | ---- | ---- | ---- | -87.22%510K |
| Cash inflows from financing activities | ---- | -60.47%50M | -60.37%50.1M | -56.87%50M | ---- | -66.57%126.49M | -65.56%126.41M | -29.00%115.93M | -73.71%5.5M | 77.40%378.37M |
| Borrowing repayment | 21.33%9.1M | -38.75%135.8M | -40.99%110M | -33.41%92.5M | 0.00%7.5M | 31.46%221.72M | 44.61%186.4M | 34.28%138.9M | 118.06%7.5M | 837.00%168.65M |
| Dividend interest payment | -74.11%2.27M | 198.10%172.62M | 704.46%157.92M | 540.36%90.03M | 119.73%8.79M | -57.64%57.91M | -85.41%19.63M | -77.45%14.06M | 230.07%4M | 8.83%136.71M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | 58.10%79.92M | 490.64%73.8M | ---- | ---- | --50.55M | 52.38%12.5M | ---- | ---- | ---- |
| Cash payments relating to other financing activities | -18.01%2.81M | -43.54%15.31M | -50.76%9.79M | -56.79%7.42M | -57.97%3.42M | -4.10%27.12M | 46.75%19.88M | 71.66%17.17M | 64.79%8.14M | 47.38%28.28M |
| Cash outflows from financing activities | -28.05%14.18M | 5.54%323.73M | 22.93%277.71M | 11.65%189.95M | 0.36%19.71M | -8.06%306.74M | -18.45%225.91M | -3.22%170.13M | 104.77%19.64M | 104.94%333.64M |
| Net cash flows from financing activities | 28.05%-14.18M | -51.86%-273.73M | -128.75%-227.61M | -158.21%-139.95M | -39.35%-19.71M | -503.02%-180.25M | -210.53%-99.5M | -333.26%-54.2M | -225.06%-14.14M | -11.41%44.73M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 93.11%-1.57K | ---29.45K | 92.52%-27.35K | 96.62%-22.97K | 86.22%-22.81K | ---- | -150.55%-365.61K | -6,413.45%-679.77K | -613.78%-165.53K | -2.42%-569.96K |
| Net increase in cash and cash equivalents | 275.22%146.5M | -292.92%-127.79M | 53.30%-82.49M | 13.60%-118.48M | -18.59%-83.61M | -116.88%-32.52M | -60.82%-176.65M | -251.67%-137.13M | -225.14%-70.5M | -38.68%192.65M |
| Add:Begin period cash and cash equivalents | -15.48%697.96M | -3.79%825.75M | -3.79%825.75M | -3.79%825.75M | -3.79%825.75M | 28.94%858.27M | 28.94%858.27M | 28.94%858.27M | 28.94%858.27M | 89.38%665.62M |
| End period cash equivalent | 13.79%844.45M | -15.48%697.96M | 9.04%743.25M | -1.92%707.27M | -5.79%742.14M | -3.79%825.75M | 22.64%681.62M | -4.62%721.14M | 9.11%787.77M | 28.94%858.27M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Rongcheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rongcheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rongcheng Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
The US-Iran negotiations have entered a critical window period amid external expectations and the strategic interactions of all parties, wit
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm